An Israel-based team of researchers has found an uptick in eye ailments in teens and young adults taking the anti-acne med isotretinoin, sold by Swiss drug giant Roche ($RHHBY) under the brand name Roaccutane. Roche wouldn't comment on the findings, and there have been other safety warnings on the drug in the past, Reuters reported. Article